Viking Therapeutics, Inc.VKTX
Market cap
$4B
P/E ratio
| 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | -98.3 | -112.3 | -13.6 | -8.8 | -14.6 | -23.5 | -36.3 | -32 | -17.2 |
| Return on equity (%) |
| 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | -98.3 | -112.3 | -13.6 | -8.8 | -14.6 | -23.5 | -36.3 | -32 | -17.2 |
| Return on equity (%) |